RegenxBio Inc: A Compelling Investment Opportunity!
RegenxBio, Inc (NASDAQ: RGNX) is a clinical-stage biotechnology company which is cementing its place as a global leader in gene therapies, targeting the treatment of retinal, metabolic, and neurodegenerative diseases. The Company is leveraging a proprietary NAV Technology Platform to develop a pipeline of candidates...
